SSY Group (HKG:2005) received approval for the passing of the generic drug quality and efficacy consistency evaluation for its Furosemide injection from China's National Medical Products Administration, a Friday bourse filing said.
The drug is mainly used to treat various diseases with edema, hypertension, hyperkalemia and hypercalcemia, and dilutional hyponatremia among others.